首页|孪蛋白DNA复制抑制因子基因在胰腺癌的表达及其临床意义

孪蛋白DNA复制抑制因子基因在胰腺癌的表达及其临床意义

扫码查看
目的 探讨孪蛋白DNA复制抑制因子(GMNN)基因不同表达水平在胰腺癌患者的临床意义和预后价值.方法 利用癌症基因组图谱(TCGA)数据库下载胰腺癌转录组数据和临床信息,运用生物信息学方法分析GMNN基因在胰腺癌组织中表达差异及临床病理特征相关性,使用R语言进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集分析.采用Cox回归分析胰腺癌患者生存预后影响因素,使用R包单样本基因集富集分析(ssGSEA)方法探索胰腺癌关键基因表达水平与免疫细胞浸润相关性.分别采用Wilcoxon秩检验或x2检验分析两组或多组间差异.结果 GMNN基因mRNA水平在不同病理分级胰腺癌患者之间有差异,GMNN高表达与胰腺癌病理分级,糖尿病病史,总生存(OS)之间存在显著相关性(P<0.05).GO和KEGG通路富集分析发现,相关差异基因主要影响细胞化学突触传递调节,细胞膜电位调节等信号通路.生存分析发现,低GMNN表达水平组OS显著长于高表达组[2.901(1.810,3.518)比1.416(1.153,1.717),风险比(HR)=2.229,95%置信区间(CI):1.451~3.425,P<0.01],多因素Cox回归分析显示,肿瘤残余情况和GMNN表达水平[HR=2.075(1.286~3.348),P<0.01]是影响胰腺癌患者OS的独立风险因素.免疫浸润分析发现,GMNN与抗原递呈细胞,树突状细胞细胞等多种免疫细胞浸润水平之间有密切相关性.结论 GMNN高表达患者在胰腺癌预后中OS更差,是影响胰腺癌OS的独立风险因素,其表达水平与免疫细胞浸润明显相关.
Expression of geminin DNA replication inhibitor gene in pancreatic cancer and clinical prognostic significance
Objective To investigate the clinical significance and prognostic value of different ex-pression levels of geminin DNA replication inhibitor(GMNN)gene in pancreatic cancer patients.Methods Transcriptome data and clinical information of pancreatic cancer were retrieved from The Cancer Genome Atlas(TCGA)database.Bioinformatics methods were employed to analyze the correlation between the ex-pression differences of GMNN genes in pancreatic cancer tissues and their clinicopathological characteris-tics.Gene ontology(GO)and kyoto encyclopedia of genes and genomes(KEGG)pathway enrichment ana-lyses were performed using R software.A Cox proportional regression risk model was constructed to analyze the factors influencing the survival prognosis of pancreatic cancer patients.Additionally,the R package single-sample gene set enrichment analysis(ssGSEA)method was utilized to explore the correlation be-tween the expression level of key genes in pancreatic cancer and immune cell infiltration.The differences between two or more groups were analyzed using the Wilcoxon rank test or the x2 test,respectively.Results GMNN gene mRNA levels varied among pancreatic cancer patients with different pathological grades,and there was a significant correlation between high GMNN expression and pancreatic cancer pathological grade,history of diabetes mellitus,and overall survival(OS)of the patients(P<0.05).The enrichment analysis of the GO and KEGG pathways revealed that the relevant differential genes mainly affected the reg-ulation of cellular chemical synaptic transmission,cell membrane potential regulation and other signalling pathways.Survival analysis revealed that OS was significantly longer in the low GMNN expression level group than in the high expression group[2.901(1.810,3.518)vs.1.416(1.153,1.717),hazard ratio(HR)=2.229,95%confidence interval(CI):1.451-3.425,P<0.01],and multifactorial Cox regres-sion analysis showed that tumour residual status and GMNN expression level[HR=2.075(1.286-3.348),P<0.01]were independent risk factors for OS in pancreatic cancer patients.Immune infiltration analysis revealed a robust correlation between GMNN expression and the infiltration levels of various immune cells,including antigen-presenting cells and dendritic cells.Conclusion High GMNN expression is associated with worse OS in pancreatic cancer patients,serving as an independent risk factor influencing OS.Addi-tionally,GMNN expression exhibits a significant correlation with immune cell infiltration.

Pancreatic cancerPrognosis

李潜、付蕾、马飞、王居峰

展开 >

郑州大学附属肿瘤医院,河南省肿瘤医院肿瘤内科,郑州 450008

河南省人民医院肿瘤内科,郑州 450003

郑州大学附属肿瘤医院,河南省肿瘤医院普外科,郑州 450008

胰腺癌 预后

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(2)
  • 17